M., White, E., & Chen, C.-L
This is one reason why the standard protocol involves gradual dose escalation, and it is also why the first week on semaglutide can vary so much from person to person
Summit Research Peptides received an FDA warning letter in December 2024 despite marketing their products explicitly for the scientific community and research applications. The surrounding content on their product pages made the intended use clear enough that the disclaimer provided no protection
Where available, Certificates of Analysis (COAs), analytical documentation, and batch information may be provided to support product verification
Surgery is generally reserved for cases with progressive neurological deficits, cauda equina syndrome (a surgical emergency), or persistent symptoms despite 6 to 12 months of conservative treatment
Still, we have little knowledge of the long-term effects of this substance, particularly regarding its usage for skin whitening